Goldline Pharma MD Amol Mujumdar Acquires 60,000 Shares

Amol Laxmikant Mujumdar, Promoter and Managing Director of Goldline Pharmaceutical Limited, has acquired 60,000 equity shares through an open market purchase. The acquisition, which took place on August 31, 2026, represents 0.62% of the company's total paid-up share capital. Following this transaction, Mujumdar's total shareholding in Goldline Pharmaceutical Limited increased from 28.64% to 29.27%. This disclosure is made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.